-
Contact the PP Team
Buying shares?
- Thread starter DeadlyVenom
- Start date
PYC
The Stigologist 7 May '19 - 15:38 - 4344 of 4348
UK leads the field in Healthcare/Biotech/Pharma AI/Machine Learning
Unlisted entities
Google Deepmind $500m+
Benevolent AI $2000m+
ExScientia $1000m+
Listed entities
#RENX £90m
#SENS £230m
#PYC £2m
Physiomics is undervalued by multiples. Only a matter of time before a moonshoot
The Stigologist 7 May '19 - 15:38 - 4344 of 4348
UK leads the field in Healthcare/Biotech/Pharma AI/Machine Learning
Unlisted entities
Google Deepmind $500m+
Benevolent AI $2000m+
ExScientia $1000m+
Listed entities
#RENX £90m
#SENS £230m
#PYC £2m
Physiomics is undervalued by multiples. Only a matter of time before a moonshoot
CPX
Good news on litigation settlement with Cornell
https://investegate.co.uk/cap-xx-li...nt-and-licence-agreement/201907020700091206E/
CAP-XX is pleased to announce that, following a court action, it has reached agreement with Cornell-Dubilier Electronics Inc. (CDE), whereby CDE will licence two of CAP-XX's patents on a non-exclusive basis.
CDE is a US based privately owned capacitor manufacturer with over 35,000 customers worldwide. It is also the largest manufacturer of power capacitors in North America.
The royalty rate to be paid to CAP-XX is in line with the royalty rates applicable to other licence agreements with third parties. No further financial details relating to the transaction will be disclosed due to confidentiality provisions in the settlement.
Anthony Kongats, Chief Executive of CAP-XX said:
"We are delighted that CDE has settled our action. This settlement reinforces the integrity of our intellectual property, which is critical to the production of supercapacitors as well as other related applications."
Good news on litigation settlement with Cornell
https://investegate.co.uk/cap-xx-li...nt-and-licence-agreement/201907020700091206E/
CAP-XX is pleased to announce that, following a court action, it has reached agreement with Cornell-Dubilier Electronics Inc. (CDE), whereby CDE will licence two of CAP-XX's patents on a non-exclusive basis.
CDE is a US based privately owned capacitor manufacturer with over 35,000 customers worldwide. It is also the largest manufacturer of power capacitors in North America.
The royalty rate to be paid to CAP-XX is in line with the royalty rates applicable to other licence agreements with third parties. No further financial details relating to the transaction will be disclosed due to confidentiality provisions in the settlement.
Anthony Kongats, Chief Executive of CAP-XX said:
"We are delighted that CDE has settled our action. This settlement reinforces the integrity of our intellectual property, which is critical to the production of supercapacitors as well as other related applications."
Majestic_Inzi
First Class Star
- Joined
- Feb 9, 2007
- Runs
- 3,970
I3e is a good stock to watch.
If you want a risky one, look at zen, currently well deepening c37. 2p reserved 31m and mkt cap only 9m.
If you want a risky one, look at zen, currently well deepening c37. 2p reserved 31m and mkt cap only 9m.
TRT this looks a huge endorsement from Bridgestone for a tyre technology firm like Transense
Bridgestone offering them an interest free loan of almost $1m
Requiring TRT not enter into takeover talks with any other party for 6 months
Looks like Bridgestone think the tech is good and worth investigating further before striking themselves or not
https://investegate.co.uk/transense...reement-with-bridgestone/201908130700107940I/
Bridgestone offering them an interest free loan of almost $1m
Requiring TRT not enter into takeover talks with any other party for 6 months
Looks like Bridgestone think the tech is good and worth investigating further before striking themselves or not
https://investegate.co.uk/transense...reement-with-bridgestone/201908130700107940I/
Excellent.
AOR comparitor Foldax has started putting their heart valves into human trials so things are moving fast. I have heard talk of Goldman Sachs investing in Foldax at a $1.4bn valuation.
Foldax was set up by ex AorTech employees and there was a long running legal dispute between the two companies before they agreed to 'drop hands' (settlement unknown) and pursue the commercialisation of the technology. AorTech are a couple of years behind but this is such a huge market with many large players that both Foldax and AorTech have chance to succeed for their respective shareholders.
AorTech currently valued at £10m
Real ten bagger potential
AOR comparitor Foldax has started putting their heart valves into human trials so things are moving fast. I have heard talk of Goldman Sachs investing in Foldax at a $1.4bn valuation.
Foldax was set up by ex AorTech employees and there was a long running legal dispute between the two companies before they agreed to 'drop hands' (settlement unknown) and pursue the commercialisation of the technology. AorTech are a couple of years behind but this is such a huge market with many large players that both Foldax and AorTech have chance to succeed for their respective shareholders.
AorTech currently valued at £10m
Real ten bagger potential
AOR
landy90 19 Oct '19 - 08:15 - 2772 of 2772
I find the Biomerics Tweet very interesting. Biomerics is a sub contract manufacturer for all the big device companies. They are very customer focussed. My guess is their customers have been asking them about Aortech. The industry has been a bit dismissive of polymer valves in the past but is now taking real notice of the recent first in man. Polymer valves and Elasteon are being talked about!!
landy90 19 Oct '19 - 08:15 - 2772 of 2772
I find the Biomerics Tweet very interesting. Biomerics is a sub contract manufacturer for all the big device companies. They are very customer focussed. My guess is their customers have been asking them about Aortech. The industry has been a bit dismissive of polymer valves in the past but is now taking real notice of the recent first in man. Polymer valves and Elasteon are being talked about!!
CPX Having followed it for a long time I think it's 'due' an up wave at some point and if it cracks that Automotive market it will be a big wave.
Apparently CPX are now in legal dispute with Tesla owned Maxwell !
I think CPX have exceptional IPR. It might be cheaper for a Company to just buy them rather than pay licensing fees AND risk competitors getting their IPR cheap ?
pefect time to take out a mortgage on your home and invest all of it into the only thing with any value in the current climaate.
why is it the perfect time?
we are looking down the barrel of another economic crisis, recession is due to hit within the next 2 years, worldwide debt is at an all time high.
when the recession hits, it will be worse than last time, every country will be affected, currencies will devalue like crazy.
what will be the safe haven?
the world will rush to find something where there assets are safe and will not devalue.
what is the only asset to be able to multiply like crazy in these tough times?
there is only one thing out there...
bitcoin
don't miss out, shares will not make you rich, secure yours and your children's future by getting a piece of the pie.
there is plenty for everyone to get hold of.
why is it the perfect time?
we are looking down the barrel of another economic crisis, recession is due to hit within the next 2 years, worldwide debt is at an all time high.
when the recession hits, it will be worse than last time, every country will be affected, currencies will devalue like crazy.
what will be the safe haven?
the world will rush to find something where there assets are safe and will not devalue.
what is the only asset to be able to multiply like crazy in these tough times?
there is only one thing out there...
bitcoin
don't miss out, shares will not make you rich, secure yours and your children's future by getting a piece of the pie.
there is plenty for everyone to get hold of.
Renewal from Merck who are one of the most forward thinking of larger Pharmaceutical companies
Great endorsement
I see this as basically Merck validating and funding Physiomics R&D
A chap called Ali Mortazavi a pro Trader, financier and ex-CEO of Silence Therapeutics (SLN) has opined that UK biotech sector is ridiculously cheap. Even the bad ones.
I have positions in PYC, ETX (both AI plays on biotech), C4XD, TRX, AOR, IMM, AVCT
I have positions in PYC, ETX (both AI plays on biotech), C4XD, TRX, AOR, IMM, AVCT
C4XD C4X Discovery
This seemed to have been impacted by the poor market and poor timing of a fundraising. Science seems really interesting and commercial deals in offing. Entrepreneur behind company Clive Dix seemed genuinely contrite about having had to do such a badly timed and discounted placing... but it is out of the way for a year
This seemed to have been impacted by the poor market and poor timing of a fundraising. Science seems really interesting and commercial deals in offing. Entrepreneur behind company Clive Dix seemed genuinely contrite about having had to do such a badly timed and discounted placing... but it is out of the way for a year
Gold on a tear higher
Should be reflected in small micro-cap goldies at some point (many of whose projects use $1200 / oz Gold price in their NPV/DCFs etc but should be updated given current spot is $1500 / oz and rising)
Should spur M&A if not noticed by private investors/Institutions
Adding charts of CNR, ORR, XTR
Should be reflected in small micro-cap goldies at some point (many of whose projects use $1200 / oz Gold price in their NPV/DCFs etc but should be updated given current spot is $1500 / oz and rising)
Should spur M&A if not noticed by private investors/Institutions
Adding charts of CNR, ORR, XTR
On the subject of AVCT
Somebody unearthed this post on another BB of some top science fella from Roche joining them. Sounds very interesting. Been a few decent sounding deals with likes of LG Chem and Daewoong recently as well.
Bumpa33 13 Dec '18 - 08:33 - 1788 of 2883
from shareprophets this morning...
This may be the first time I’ve written three wall-to-wall articles about any company. But yet more positive news has broken from Avacta (AVCT), the medical pioneer. And I think it makes considering this interesting share even more compelling...
Earlier this week came news that a big South Korean pharma has agreed to partner with Avacta. It will support the Yorkshire medical pioneer to the tune of up to $180 million for development. In addition, royalties will find their way into Avacta’s coffers. But now comes more good news.
The company has appointed a new Chief Medical Officer. His job will be to ‘drive’ research and development projects into clinics. In other words: to make Avacta’s scientific progress translate into diagnostics and treatments. The new man is Dr Jose Saro, who joins Avacta from the mighty Swiss pharma Roche. What’s exciting is that Doctor Saro is a big name in the field. He has over 20 years’ experience in the early development of cancer treatment.
At Roche, Dr Saro was senior ‘Transational Medicine Leader’ at Roche’s Innovation centre in Zurich. Before that, he’s worked for Bristol Myers Squibb and Novartis. He seems to have worked mostly in oncology, which is, of course, treatment of cancer. Avacta is cocker hoop at securing the doctor’s services. He himself is very impressed by affimer proteins, which Avacta is developing as alternatives to antibodies in medical treatment. He says ‘Due to their simple structure, affimer proteins can be formatted to deliver the right characteristics required for the next generation of immuno-oncology therapeutics.’
Dr Saro believes that affimers will have ‘a huge benefit’ to cancer patients who currently have limited affective means of treatment. I don’t have to tell you, chums, that boffins all over the world are looking for better cancer diagnosis and treatment. And with this new chap in charge of bringing Avacta innovations to the market, this might be a tasty investment. But I realise I may be too enthusiastic about Avacta, especially as all medical pioneering can be risky. So please make up your own mind.
Somebody unearthed this post on another BB of some top science fella from Roche joining them. Sounds very interesting. Been a few decent sounding deals with likes of LG Chem and Daewoong recently as well.
Bumpa33 13 Dec '18 - 08:33 - 1788 of 2883
from shareprophets this morning...
This may be the first time I’ve written three wall-to-wall articles about any company. But yet more positive news has broken from Avacta (AVCT), the medical pioneer. And I think it makes considering this interesting share even more compelling...
Earlier this week came news that a big South Korean pharma has agreed to partner with Avacta. It will support the Yorkshire medical pioneer to the tune of up to $180 million for development. In addition, royalties will find their way into Avacta’s coffers. But now comes more good news.
The company has appointed a new Chief Medical Officer. His job will be to ‘drive’ research and development projects into clinics. In other words: to make Avacta’s scientific progress translate into diagnostics and treatments. The new man is Dr Jose Saro, who joins Avacta from the mighty Swiss pharma Roche. What’s exciting is that Doctor Saro is a big name in the field. He has over 20 years’ experience in the early development of cancer treatment.
At Roche, Dr Saro was senior ‘Transational Medicine Leader’ at Roche’s Innovation centre in Zurich. Before that, he’s worked for Bristol Myers Squibb and Novartis. He seems to have worked mostly in oncology, which is, of course, treatment of cancer. Avacta is cocker hoop at securing the doctor’s services. He himself is very impressed by affimer proteins, which Avacta is developing as alternatives to antibodies in medical treatment. He says ‘Due to their simple structure, affimer proteins can be formatted to deliver the right characteristics required for the next generation of immuno-oncology therapeutics.’
Dr Saro believes that affimers will have ‘a huge benefit’ to cancer patients who currently have limited affective means of treatment. I don’t have to tell you, chums, that boffins all over the world are looking for better cancer diagnosis and treatment. And with this new chap in charge of bringing Avacta innovations to the market, this might be a tasty investment. But I realise I may be too enthusiastic about Avacta, especially as all medical pioneering can be risky. So please make up your own mind.
Couch Cricketer
First Class Star
- Joined
- Oct 31, 2007
- Runs
- 3,512
I got out of the market last week when I heard some of the rumors for the coronavirus. It looks to me the correct decision observing the markets today and yesterday. I mostly buy tech funds instead of trading directly and for last 2-3 weeks I was feeling that tech stocks/nasdaq were due for a 5-8% correction. Still was hesitating getting out as most of companies would be announcing 4th quarter results. Now will need to decide when to get back in. My previous buy in was just after the market had crashed in around dec 2018 because of some Apple news. Didn't get in fast enough that time so just made 40% profit of that trade could have made 50-55% had I timed it better.
I would advise if you are invested in anything exposed to chinese and asian markets to hedge your investments as this could be worse that the previous Sars epidemic in 03-04
I would advise if you are invested in anything exposed to chinese and asian markets to hedge your investments as this could be worse that the previous Sars epidemic in 03-04
Nice RNS from AOR Today
https://www.lse.co.uk/rns/AOR/propo...-medical-and-name-change-7alvv7q47p4azsb.html
https://www.lse.co.uk/rns/AOR/propo...-medical-and-name-change-7alvv7q47p4azsb.html
Yes in effect a Reverse Takeover. Not a great 'premium' with the 'Vendor' taking stock at 100p (a premium to the prevailing market price but significantly below recent Analyst price target of 676p !)
Overall I see it as positive. There will be a younger management team who look to have the skills to take AOR's IPR all the way to FDA approval and beyond.
Overall I see it as positive. There will be a younger management team who look to have the skills to take AOR's IPR all the way to FDA approval and beyond.
Couch Cricketer
First Class Star
- Joined
- Oct 31, 2007
- Runs
- 3,512
I am patting myself on the back now though I only got out looking at how american tech stocks were exposed to the asian market. I am too risk averse to short or would have made a killing. Market is still unstable but prices are down so much that if anyone has the capacity to hold long term it might be getting time to buy in.
It's a market of stocks not a stockmarket
Usually a good idea though to buy (using pound or dollar cost averaging approach) at these times of panic if you are a long term investor as part of a diversified portfolio
VIX peaked at c. 75-80 during Global Financial Crisis in 2008
Today hit 79 intraday. Currently 75
Usually a good contra indicator
Usually a good idea though to buy (using pound or dollar cost averaging approach) at these times of panic if you are a long term investor as part of a diversified portfolio
VIX peaked at c. 75-80 during Global Financial Crisis in 2008
Today hit 79 intraday. Currently 75
Usually a good contra indicator
JaDed
Test Star
- Joined
- May 5, 2014
- Runs
- 37,635
Markets absolutely getting a pounding. Great oppurtunity for everyone to buy now and retire happily.
Lloys bank trading at 33pence...jeez
FTSE 100 trading at 4937
You are in UK? Is it something about that country that as soon as some desi goes there they become obnoxious and politically religious?
Dow drops nearly 3,000 points, as coronavirus collapse continues; worst day since '87
Stocks fell sharply Monday — with the Dow suffering its worst day since the "Black Monday" market crash in 1987 and its third-worst day ever — even after the Federal Reserve embarked on a massive monetary stimulus campaign to curb slower economic growth amid the coronavirus outbreak.
The Dow Jones Industrial Average closed 2,997.10 points lower, or 12.9%, at 20,188.52. The 30-stock Dow was briefly down more than 3,000 points in the final minutes of trading. The S&P 500 dropped 12% to 2,386.13 — hitting its lowest level since December 2018 — while the Nasdaq Composite closed 12.3% lower at 6,904.59 in its worst day ever.
"The markets are getting no break with yesterday's historic Fed actions and COVID-19 dominating the world's headlines," Frank Cappelleri, executive director at Instinet, said in a note. "While the news continues to worsen and with the price action doing things we've only seen a handful of other times in the last century, it's nearly impossible to keep things in perspective."
"We can't argue the facts, and we're dealing with a much bigger issue than just the economy," Cappelleri said.
The major averages fell to their lows into the close after President Donald Trump said the worst of the outbreak could last until August. He also told reporters the U.S. "may be" heading into a recession.
"The market didn't hear what it wanted to hear. I don't think that it wanted to hear that this was going to last until July and August, and now the market does the math. If it lasts until July and August, that means we maybe have a contraction in the second quarter and the third quarter, and that means recession," BNY Mellon strategist Liz Young said on CNBC's "Closing Bell."
Monday's losses put the Dow down 31.7% from its all-time high and the S&P 500 and Nasdaq more than 29% below their records last month. The Dow fell to its lowest point since 2017.
The Dow's drop was the worst decline since its "Black Monday" crash three decades ago when it fell more than 22%. The drop surpassed its 9.99% tumble last Thursday. It was also the Dow's third-worst day ever; it dropped more than 13% in late 1929.
https://www.cnbc.com/2020/03/15/tra...r-fed-cuts-rates-launches-easing-program.html
Stocks fell sharply Monday — with the Dow suffering its worst day since the "Black Monday" market crash in 1987 and its third-worst day ever — even after the Federal Reserve embarked on a massive monetary stimulus campaign to curb slower economic growth amid the coronavirus outbreak.
The Dow Jones Industrial Average closed 2,997.10 points lower, or 12.9%, at 20,188.52. The 30-stock Dow was briefly down more than 3,000 points in the final minutes of trading. The S&P 500 dropped 12% to 2,386.13 — hitting its lowest level since December 2018 — while the Nasdaq Composite closed 12.3% lower at 6,904.59 in its worst day ever.
"The markets are getting no break with yesterday's historic Fed actions and COVID-19 dominating the world's headlines," Frank Cappelleri, executive director at Instinet, said in a note. "While the news continues to worsen and with the price action doing things we've only seen a handful of other times in the last century, it's nearly impossible to keep things in perspective."
"We can't argue the facts, and we're dealing with a much bigger issue than just the economy," Cappelleri said.
The major averages fell to their lows into the close after President Donald Trump said the worst of the outbreak could last until August. He also told reporters the U.S. "may be" heading into a recession.
"The market didn't hear what it wanted to hear. I don't think that it wanted to hear that this was going to last until July and August, and now the market does the math. If it lasts until July and August, that means we maybe have a contraction in the second quarter and the third quarter, and that means recession," BNY Mellon strategist Liz Young said on CNBC's "Closing Bell."
Monday's losses put the Dow down 31.7% from its all-time high and the S&P 500 and Nasdaq more than 29% below their records last month. The Dow fell to its lowest point since 2017.
The Dow's drop was the worst decline since its "Black Monday" crash three decades ago when it fell more than 22%. The drop surpassed its 9.99% tumble last Thursday. It was also the Dow's third-worst day ever; it dropped more than 13% in late 1929.
https://www.cnbc.com/2020/03/15/tra...r-fed-cuts-rates-launches-easing-program.html
jaspa888
Local Club Star
- Joined
- Aug 1, 2007
- Runs
- 1,984
Some crazy drops in FTSE. Will get worse before it gets better.
Looking to pick up banking and oil stocks on main markets in next week or so.
Looking to pick up banking and oil stocks on main markets in next week or so.
Ftse100 up today but by just. I picked up few LLOY and BP. shares yesterday. Prices are too tempting now not to but it could fall further.
Can you share a website/URL to purchase shares and perhaps share the process. Is it quite simple to purchase shares in UK.
King-Misbah
First Class Player
- Joined
- Jan 8, 2017
- Runs
- 2,799
I think there will be some issues in buying shares due to liquidity issues (caused by erratical price movements). Trade with a goof broker.
Last edited:
There are many brokers like IG, Hargreaves Lansdown, Saxo Markets, Degiro, CMC markets, Interactive investors, Barclays etc. I use Hargreaves but you can choose the best for you. Its pretty simple - just register, they will do some kyc checks, deposit money and start trading. (But always keeping risk in mind
)One area I am concentrating on right now is Computational Biology/AI/ML
These sort of Companies do most of their work in-silico (on computers/networks) so can assist Biotechs and Pharma companies to continue to 'Work-From-Home' during the current Global Pandemic
I would expect them all to get more business from existing customers, more inquiries from potential new customers and a higher appreciation and rating from investors in aftermath of this present crisis
Those Companies in this sector I particularly like are
ETX e-therapeutics
C4XD C4X Discovery
PYC Physiomics
A video outlining some of the ways C4X for example utilise computing to discover and develop new drugs
<iframe width="560" height="315" src="https://www.youtube.com/embed/ntljiVNXgvI" frameborder="0" allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen></iframe>
These sort of Companies do most of their work in-silico (on computers/networks) so can assist Biotechs and Pharma companies to continue to 'Work-From-Home' during the current Global Pandemic
I would expect them all to get more business from existing customers, more inquiries from potential new customers and a higher appreciation and rating from investors in aftermath of this present crisis
Those Companies in this sector I particularly like are
ETX e-therapeutics
C4XD C4X Discovery
PYC Physiomics
A video outlining some of the ways C4X for example utilise computing to discover and develop new drugs
<iframe width="560" height="315" src="https://www.youtube.com/embed/ntljiVNXgvI" frameborder="0" allow="accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture" allowfullscreen></iframe>
US and UK Governments throwing unprecedented amounts of cash at Capitalism to keep it alive
My portfolio largely comprised of stocks illustrated in charts above is almost 'unscathed' (unlike my mental wellbeing which is very scathed) by the last month or so
My portfolio largely comprised of stocks illustrated in charts above is almost 'unscathed' (unlike my mental wellbeing which is very scathed) by the last month or so
Etx
Incredible relative strength during a Global Pandemic, Worldwide economic recession and Stockmarket Crash.
I happen to think it's because the market is waking up to the fact AI/ML/Computational Biology is THE FUTURE.
This technology platform could not just help Big Pharma become more productive and efficient but if they go it alone Companies like this could become the MEGA-Pharmas of the Future.
All banks in UK (LLOY, BARC, RBS, HSBC etc) suspend dividents.
https://www.cityam.com/coronavirus-barclays-bank-suspends-dividend-for-2020/
https://www.cityam.com/coronavirus-barclays-bank-suspends-dividend-for-2020/
shaz619
Test Star
- Joined
- Mar 31, 2010
- Runs
- 36,688
- Post of the Week
- 7
I am looking to get into this on a small scale, perhaps now is the best time to buy shares
What are your thoughts on trading 212 ?
For newbies, what's the difference between trading in CFD, to Invest and ISA - which option is best to start with, great thing about trading 212 is they allow you to practice
What are your thoughts on trading 212 ?
For newbies, what's the difference between trading in CFD, to Invest and ISA - which option is best to start with, great thing about trading 212 is they allow you to practice
CFD or spread betting is very risky, especially for new investors. There are high chances you would lose money.
The best and low risk option is to open an ISA account and invest in index trading funds. Diversify it amongs funds so that it covers most indexes - FTSE, Dow, ex-Europe, emerging markets etc. Investing in funds is easy because there is a fund manager who is working for you and you dont need to worry about it every day.
Another option is to invest directly in equity. Little more work and risky than funds but returns will also be higher. Now with all global markets down, its a good time to have Warren Buffet approach. Buy good companies dirt cheap and never sell. Investing in blue chip companies like Aamazon, Microsoft, Facebook, JP Morgan, British Petrolium, IAG etc. can give good benefits in future. But investing in equity directly is little risky than funds.
I think the stats show (they often have to publish this in the small print) about 80-90% of spreadbet/cfd accounts lose money. You need to know what you are doing because you are trading on leverage. I've known pro-traders get wiped out on those accounts. And I mean wiped out of the game alltogether.
Best to start with a regular savings type account and 'pound cost average' or 'dollar cost average' into funds/stocks
https://www.investopedia.com/terms/d/dollarcostaveraging.asp
When I first started (back in the 1990s) I stuck to what I thought I knew investing in football club shares
You could at that time buy shares in Manchester United, Arsenal and Liverpool when the whole clubs were valued at only c.£10m (they're now all valued at £1000m+ because of inflation / media rights / understanding of their global brand appeal etc)
If you do opt for stocks its a good idea to initially stick to companies/products you know. e.g. if you were into cars why not look at companies that supply the auto industry for example
Best to start with a regular savings type account and 'pound cost average' or 'dollar cost average' into funds/stocks
https://www.investopedia.com/terms/d/dollarcostaveraging.asp
When I first started (back in the 1990s) I stuck to what I thought I knew investing in football club shares
You could at that time buy shares in Manchester United, Arsenal and Liverpool when the whole clubs were valued at only c.£10m (they're now all valued at £1000m+ because of inflation / media rights / understanding of their global brand appeal etc)
If you do opt for stocks its a good idea to initially stick to companies/products you know. e.g. if you were into cars why not look at companies that supply the auto industry for example
shaz619
Test Star
- Joined
- Mar 31, 2010
- Runs
- 36,688
- Post of the Week
- 7
Yes that does seem to be the consensus surrounding CFD, wanted to understand what they are for the general info. How do ISA's work from what I've seen these are mostly offered through banks for "savings' however I avoided these due to the variable rate and the standard savers accounts seemed more appealing for this like housing deposit. What are index trading funds and examples of investing in equity ? additionally how does diversification work.
Yes, I have seen this on a personal level the dirt cheap value out there right now and it got me curious in terms of how this is affecting industries outside aviation, for the most part most have seen decline in the share value it seems to me it would be a good time to get what you're able to for now and sitting on those shares.
Similar threads
